Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00674492 · ClinicalTrials.gov registry record
Hepatitis C Virus (HCV) Treatment Completion or Withdrawal
A clinical trial, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 21
- Enrollment target
NCT00674492: Completed study, sponsored by US Department of Veterans Affairs.
NCT00674492 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00674492 has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
Qualitative pilot study of patients' views of their experience with antiviral treatment for hepatitis C.
Primary Outcome
Four basic reasons for persisting in antiviral treatment were identified: cure the disease, concern about diminishing time to act (avoid bad end), demonstation of personal strength, and redemption for past behavior.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2008-05 |
| Est. Completion | 2008-08 |
What the finished NCT00674492 record still lists
NCT00674492 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00674492 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00674492 about?
NCT00674492 is a clinical study titled "Hepatitis C Virus (HCV) Treatment Completion or Withdrawal". Qualitative pilot study of patients' views of their experience with antiviral treatment for hepatitis C.
What is the current status of trial NCT00674492?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2008-05. Estimated completion is 2008-08.
Who is sponsoring clinical trial NCT00674492?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia